Direct Measure of the De Novo Mutation Rate in Autism and Schizophrenia Cohorts

Philip Awadalla(Ontario Institute for Cancer Research), Guy A. Rouleau(Montreal Neurological Institute and Hospital), Éric Fombonne(Oregon Health & Science University), Yanlian Yang(National Center for Nanoscience and Technology), Judith L. Rapoport(National Institute of Mental Health), Jon Keebler(North Carolina State University), Rachel A. Myers(Duke University), Marie‐Pierre Dubé(Montreal Heart Institute), Carlos D. Bustamante(Galena Biopharma (United States)), Alexander R. Griffing(North Carolina State University), Hussein Daoud(Université de Montréal), Amélie Piton(Centre National de la Recherche Scientifique), Julien Tarabeux, Eric A. Stone, Laurent Mottron(Centres Intégré Universitaires de Santé et de Services Sociaux), Ferrán Casals(Universitat Pompeu Fabra), Claude Marineau(Centre Hospitalier de l’Université de Montréal), Bruno Millet(Centre National de la Recherche Scientifique), Pierre Drapeau(Université de Montréal), Martine Zilversmit(Université de Montréal), Adam R. Boyko(Cornell University), Ridha Joober(McGill University), Dan Spiegelman(Montreal Neurological Institute and Hospital), Marie‐Hélène Roy‐Gagnon(University of Ottawa), Édouard Henrion(Ontario Genomics), Ronald G. Lafrenière(Xenon Pharmaceuticals (Canada)), Adam Eyre‐Walker(University of Sussex), Anjené Addington(National Institute of Mental Health), Fadi F. Hamdan(Centre Hospitalier Universitaire Sainte-Justine), Lan Xiong(Université de Montréal), Julie Gauthier(Centre Hospitalier Universitaire Sainte-Justine), Marie‐Odile Krebs(Inserm), Mélanie Côté(Centre Hospitalier de l’Université de Montréal), J. Lynn E. DeLisi(Nathan Kline Institute for Psychiatric Research)
The American Journal of Human Genetics
August 27, 2010
Cited by 249


Related Papers